Products

Online Inquiry

Name

Email *

Phone *

Company/Institution

Country or Region

Quantity

Services & Products Interested *

Project Description

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Oligosaccharide reducing-end xylanase 8A from Bacillus halodurans, Recombinant

inquiry

Cat No.

NATE-1515

Description

Oligosaccharide reducing-end xylanase (EC 3.2.1.156, Rex, reducing end xylose-releasing exo-oligoxylanase) is an enzyme with systematic name beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose reducing-end xylanase. This enzyme catalyses the following chemical reaction: Hydrolysis of (1->4)-beta-D-xylose residues from the reducing end of oligosaccharides. The enzyme acts rapidly on the beta-anomer of beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose.

Abbr

Rex 8A, Recombinant (Bacillus halodurans)

Source

E. coli

Species

Bacillus halodurans

Form

35 mM NaHepes buffer, pH 7.5, 750 mM NaCl, 200 mM imidazol, 3.5 mM CaCl2, 0.02% sodium azide and 25% (v/v) glycerol

Enzyme Commission Number

EC 3.2.1.156

CAS No.

879497-03-7

Molecular Weight

47.1 kDa

Purity

>90% as judged by SDS-PAGE

Concentration

1 mg/mL

Specificity

Xylooligosaccharides whose degree of polymerization is greater than or equal to 3

Optimum pH

7.0-7.5

Optimum temperature

40 °C

Storage

This enzyme is shipped at room temperature but should be stored at -20 °C.

Synonyms

Oligosaccharide reducing-end xylanase; EC 3.2.1.156; Rex; reducing end xylose-releasing exo-oligoxylanase; beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose reducing-end xylanase

"Oligosaccharide reducing-end xylanase" Total Products Page

Enzymes

Catalog	Product Name	EC No.	CAS No.	Source	Price
NATE-1516	Oligosaccharide reducing-end xylanase 8A from Bifidobacterium adolescentis, Recombinant	EC 3.2.1.156	879497-03-7	E. coli	Inquiry
EXWM-3839	oligosaccharide reducing-end xylanase	EC 3.2.1.156	879497-03-7		Inquiry